Global Molecular Diagnostics Market Size, Status and Forecast 2019-2025

Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes.
The basic components of these systems include thermal cycler for automating the temperature cycling required in the PCR; optical systems for detection; and software to control the instrument and analyze the data. Liquid handling systems are used to dispense selected quantity of reagents, liquids, or samples to a container. These systems work on the principle of suction and are available as single or multi-channel systems. DNA Extraction systems are employed for streamlining the process of DNA extraction and automatic extraction of DNA from a variety of samples. These systems are employed as they are less time consuming, more efficient than the manual methods, and less prone to analytical errors.
In 2018, the global Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Molecular Diagnostics development in United States, Europe and China.

The key players covered in this study
Agilent Technologies
BD
Bio-Rad Laboratories
Danaher Corporation
F. Hoffmann-La Roche
Eppendorf
PerkinElmer
Tecan Group
Thermo Fisher Scientific
QIAGEN N.V.

Market segment by Type, the product can be split into
Real Time- PCR Systems
Liquid Handling System
NA Extraction System

Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.